Genetic Technologies GeneType Risk Assessment Test

Genetic Technologies has globally launched its GeneType Risk Assessment test for the EasyDNA platform. GeneType Risk Assessment is a comprehensive solution for understanding a patient's personal risk of a range of common diseases including breast cancer, colorectal cancer, ovarian cancer, coronary artery disease, prostate cancer, and type 2 diabetes, the company said. The test is ordered by a phyisician, who collects a buccal swab from a patient and returns it to GeneType, a wholly owned subsidiary of Genetic Technologies. The results are intended to help physicians translate a patient's personal clinical, family, and genetic data into an actionable preventable health plan. Genetic Technologies said that it has built a streamlined online process for both clinicians and consumers with partners Nest Genomics, DNA Nexus, DNA Visit, Gene By Gene, and Fabric Genomics.